Home › Prostate Cancer › NCT06270043

Focal Therapy for Localized Prostate Cancer

A Prospective Registry and Longitudinal Study of Patients Undergoing Focal Therapy for Localized Prostate Cancer

Who can join

Ages 18 and older · Men · Healthy volunteers welcome

Inclusion Criteria:

* Subject has elected or already undergone focal therapy as their standard of care treatment method and declined alternative treatment (active surveillance, radical prostatectomy, and radiation therapy)
* PSA ≤ 20
* Ability to complete informed consent form

Exclusion Criteria:

* Contraindication to follow-up multi parametric MRI or prostate biopsy
* Unable to tolerate general or regional anesthesia

About the study

This prospective registry and longitudinal study that is designed to carefully measure details of prostate cancer patients' outcomes with focal therapy. The goal of which is to improve patient care.

What is being tested

• Focal Therapy (procedure)

Sponsor: University of California, San Diego · Participants: 500 · Started: Feb 1, 2024

Contact the study team

• Juan Javier-DesLoges, MD · Phone: 858-657-8786

Official record on ClinicalTrials.gov — NCT06270043

Locations in the U.S.

Conditions

• Prostate Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.